Gayle Furgurson Wellborn sold $425k of HQY
director at HEALTHEQUITY, INC.. 4,339 shares at an average of $98.03, traded Dec 12, 2025, filed Dec 16, 2025.
Score components
- +15RoleDirector
- +17Trade size$425k at market
- +5Share of holdings soldSold 18% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -9.4%, 3m -17.3%, 6m -10.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001712960-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | MOption exercise Common Stock | +4,339 | $50.41 | $219k | 24,072 | Dec 16, 2025 |
| Dec 12, 2025 | SOpen-market sale Common Stock | -4,339 | $98.03 | $425k | 19,733 | Dec 16, 2025 |
| Dec 12, 2025 | MOption exercise Stock Options (right to buy)derivative | -4,339 | $0.00 | $0 | 0 | Dec 16, 2025 |
Related signals
Other insiders at HEALTHEQUITY, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 7Weak | HEALTHEQUITY, INC. | Adrian T Dillon director | $798k 7,632 shares | -11% | |
| 7Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $224k 2,354 shares | -4% | |
| 8Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $235k 2,470 shares | -4% | |
| 24Weak | HEALTHEQUITY, INC. | Michael Henry Fiore EVP, CHIEF COMMERCIAL OFFICER | $298k 3,142 shares | -5% | |
| 30Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $675k 7,500 shares | -8% | |
| 12Weak | HEALTHEQUITY, INC. | Gayle Furgurson Wellborn director | $220k 2,439 shares | -11% | |
| 21Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $142k 1,500 shares | -2% | |
| 60Notable | HEALTHEQUITY, INC. | Elimelech Rosner EVP, CHIEF TECHNOLOGY OFFICER | $1.0M 10,959 shares | -19% | |
| 6Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $157k 1,500 shares | -2% | |
| 14Weak | HEALTHEQUITY, INC. | Delano Ladd EVP, General Counsel | $138k 1,500 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.